Desjardins Capital

Desjardins Capital is the private equity and venture capital arm of Mouvement des caisses Desjardins, based in Quebec, Canada. It provides growth capital, mezzanine, and select debt financing to early-stage through mature companies across industrial, manufacturing, technology, and service sectors, with emphasis on health care, life sciences, and biotechnology. The firm also supports cooperatives, including worker-owned and housing cooperatives, and network cooperatives, financing development, acquisitions, expansions, and succession plans. It primarily invests in Quebec and surrounding regions, and can finance growth, acquisitions, management buyouts, and modernization. Investments may be equity or debt, including unsecured loans, with instruments ranging from senior debt to equity, and tenures typically five to eight years for equity and three to five years for debt. The firm often takes minority stakes with board participation. It does not invest in natural resource exploration or financial services. Desjardins Capital traces its roots to 1974 and operates within the Desjardins Group.

Daniel Archambault

Investment Manager

Nathalie Bernard

COO

Eric Bolduc

Investment Director

Jean-Yves Bourgeois

Managing Director and Group Head, Capital Markets

Jean-Philippe Bujold

Investment Manager

Past deals in Montreal

Puzzle Medical Devices

Series A in 2025
Puzzle Medical Devices develops innovative heart pump solutions to treat advanced heart failure. Its flagship product, ModulHeart, is a modular percutaneous device designed to reduce cardiac afterload and improve renal perfusion. The device's unique design enables safe percutaneous implantation, supporting both renal and cardiac function with low risk of complications. Puzzle Medical has successfully completed its first-in-human study, demonstrating improvements in cardiac and kidney function.

MY01

Series A in 2023
Founded in 2015, MY01 specializes in developing digital medical devices for accurate real-time muscle pressure measurement. Its flagship product is designed to enhance the diagnosis of Acute Compartment Syndrome (ACS) by providing timely and precise measurements.

Puzzle Medical Devices

Series A in 2023
Puzzle Medical Devices develops innovative heart pump solutions to treat advanced heart failure. Its flagship product, ModulHeart, is a modular percutaneous device designed to reduce cardiac afterload and improve renal perfusion. The device's unique design enables safe percutaneous implantation, supporting both renal and cardiac function with low risk of complications. Puzzle Medical has successfully completed its first-in-human study, demonstrating improvements in cardiac and kidney function.

Groupe Canva

Venture Round in 2022
Canva Group is a dynamic holding company in the identification and visual communications field with 9 complementary companies acquired over the last 15 years. Operating with 3 different autonomous business units under the names of Idenco Canada (Boucherville), Decalcomanie Artistic (Montreal) and Mirazed in (St-Hubert), the 200-employee company serves more than 4,000 customers with its complementary serigraphy and digital printing services. Their goal is to create the best customer experience.

Prehos

Seed Round in 2022
Founded in Quebec City, Canada in 2015, Prehos is a technology company dedicated to enhancing patient care through innovative solutions for paramedical and extra-hospital services. Its platform optimizes prehospital care tasks by integrating cartography, real-time traffic conditions, and emergency department status.

RenoRun

Series B in 2022
RenoRun Inc. is a construction materials delivery company that caters to the needs of the construction industry. Founded in 2016 and headquartered in Montreal, Canada, the company offers a wide range of products, including beams, bricks, and concrete mixes. RenoRun has developed a mobile-friendly platform that allows general contractors to place orders easily, streamlining the process of procuring materials. This innovative service minimizes wasted time and effort for contractors by providing efficient delivery directly to job sites, with trained runners ensuring timely collection and drop-off of materials. In addition to its Montreal headquarters, RenoRun operates in Toronto, Canada, and Austin, Texas, positioning itself as a significant player in the construction supply market.

BrainBox AI

Series A in 2021
Founded in 2017, BrainBox AI develops autonomous building technology that optimizes HVAC systems using artificial intelligence. Its cloud-based solution analyzes data to predict maintenance needs and maximize energy efficiency, reducing operational costs.

My Intelligent Machines

Seed Round in 2021
Montreal-based My Intelligent Machines designs biology software that combines artificial intelligence and systems biology to support early-stage drug development and personalized therapies. The company offers a software-as-a-service platform enabling augmented intelligence-driven simulations, patient stratification, and the identification of therapeutic targets and biomarkers. By leveraging big data and AI, it helps life-science teams design precise therapies and streamline research, while also applying its platform to agriculture to optimize production systems. The goal is to accelerate efficient, targeted therapies and improve outcomes across biopharma and related fields.

Breathe Life

Series A in 2020
Breathe Life Inc. is a Montreal-based company established in 2017 that specializes in providing a software platform for the life insurance industry. This enterprise Software-as-a-Service (SaaS) solution facilitates the digital distribution of life insurance policies, effectively removing the need for brokers. Breathe Life's platform enables insurers, distribution organizations, and advisors to enhance business operations by streamlining the policy delivery process and lowering operational costs. With features that allow consumers to create quotes and complete applications in a single session, the platform empowers users to independently purchase financial security products. Overall, Breathe Life aims to modernize and optimize how insurance companies engage with clients and manage their offerings.

BrainBox AI

Series A in 2020
Founded in 2017, BrainBox AI develops autonomous building technology that optimizes HVAC systems using artificial intelligence. Its cloud-based solution analyzes data to predict maintenance needs and maximize energy efficiency, reducing operational costs.

Groupe Canva

Venture Round in 2019
Canva Group is a dynamic holding company in the identification and visual communications field with 9 complementary companies acquired over the last 15 years. Operating with 3 different autonomous business units under the names of Idenco Canada (Boucherville), Decalcomanie Artistic (Montreal) and Mirazed in (St-Hubert), the 200-employee company serves more than 4,000 customers with its complementary serigraphy and digital printing services. Their goal is to create the best customer experience.

Sollio Cooperative Group

Venture Round in 2019
Sollio Cooperative Group, headquartered in Montreal, Quebec, is a prominent agri-food federation that serves agricultural producers and consumers across Canada. With over 60,000 members organized into nearly 70 cooperatives, Sollio Cooperative Group employs more than 13,000 individuals and generates an annual revenue of $6.3 billion. The organization operates through three main divisions: Olymel S.E.C, which encompasses meat processing brands like Olymel, Flamingo, and Lafleur; the Agri-business division, which includes brands such as La Coop, Élite, Agrocentre, Agrico, and Agromart; and the BMR Group, featuring BMR, Unimat, and Potvin & Bouchard. Established in 1922, Sollio Cooperative Group plays a crucial role in providing agricultural services and support, enabling farmers to enhance their crop production and overall operational efficiency.

My Intelligent Machines

Seed Round in 2019
Montreal-based My Intelligent Machines designs biology software that combines artificial intelligence and systems biology to support early-stage drug development and personalized therapies. The company offers a software-as-a-service platform enabling augmented intelligence-driven simulations, patient stratification, and the identification of therapeutic targets and biomarkers. By leveraging big data and AI, it helps life-science teams design precise therapies and streamline research, while also applying its platform to agriculture to optimize production systems. The goal is to accelerate efficient, targeted therapies and improve outcomes across biopharma and related fields.

Pit Caribou

Venture Round in 2019
Pit Caribou is a microbrewery founded in 2007, located in L'Anse à Beaufils on the Gaspé Peninsula in Quebec. The brewery focuses on crafting quality beers by utilizing local resources from the Gaspé region. It offers a diverse selection of wheat and red beers in various flavors, catering to a wide range of customer preferences. In addition to its production facilities, Pit Caribou operates pubs in Percé and Montreal, where patrons can enjoy their offerings. The company also features a shop for customers to purchase bottled products and a patio that allows visitors to savor their beers by the sea. Currently, Pit Caribou employs 37 people.

XCCommerce

Seed Round in 2019
Founded in 2010 and headquartered in Montreal, Canada, XCCommerce specializes in developing web-based software solutions tailored for the retail industry. The company's core offering is its Promotion Solution Suite, which enables retailers to create, manage, and track promotions across various channels, including e-commerce sites, kiosks, and point-of-sale devices. XCCommerce also provides support and implementation services, ensuring projects are delivered on time and within budget.

Dymedso

Seed Round in 2018
Dymedso Inc. is a Montreal-based company, founded in 2002, that specializes in developing innovative medical devices aimed at improving respiratory health. The company focuses on providing airway clearance therapy and enhancing bronchial drainage for patients suffering from chronic respiratory conditions. Dymedso has created a unique acoustics technology for pulmonary physiotherapy, exemplified by its flagship product, the Frequencer®. This device employs low-frequency sound acoustics to facilitate non-invasive respiratory airway clearance without the need for percussion, thereby offering a gentler alternative for patients. With a dedicated team of ten employees, Dymedso is committed to advancing medical technologies that enhance the quality of life for individuals with respiratory ailments.

Keatext

Seed Round in 2018
Keatext is a Montreal-based technology company that provides an AI-powered text analytics platform to synthesize customer feedback from multiple channels including surveys, online reviews, chat logs, social media, and support tickets. Using natural language processing, the platform consolidates data into a single view to surface actionable insights, helping businesses understand what customers care about, identify improvement opportunities, and make data-driven decisions to enhance customer experience and related outcomes.

Alyotech Canada

Venture Round in 2007
Alyotech Canada, Inc. operates through its subsidiary Groupe Conseil OSI, Inc. which provides Information Technology (IT) consulting services. The company offers management consulting and permanent placement services. Alyotech Canada is based in Montreal, Canada. Alyotech Canada, Inc. is a subsidiary of Alyotech.

Spinlogic Technologies

Venture Round in 2006
Spinlogic Technologies, Inc. provides a suite of software that enables trading partners to exchange business documents electronically. It develops and commercializes a software suite designed to optimize organizations' logistic chain, from manufacturers to distributors and retailers. The company's products include Negotium, a client-side software that enables the processing of various documents and business procedures in conformity with retailers' requirements; and the PEG-SERVR platform, which is an integrated transaction server that allows the exchange of a range of electronic documents between business partners. Spinlogic Technologies also offers PEG-Insourced, a solution that eliminates the risks associated with upgrading the current electronic data interchange (EDI) software or outsourcing the EDI system. PEG-Insourced includes hardware, software, system integration, project management, as well as technical support. The company offers its products to enterprises within the healthcare/biomedical, food and beverage, hardware/home improvement, electronics, apparel, and manufacturing/industrial sectors. The company was founded in 1998 and is based in Montreal, Canada.

Resonant Medical

Series B in 2005
Resonant Medical is a Montreal-based company focused on developing, manufacturing, and commercializing 3D ultrasound image-guided adaptive radiotherapy products for cancer treatment. Founded in 2000, the company offers innovative solutions such as the Clarity Breast System for precise guidance in breast treatments, the Clarity Prostate System for non-invasive prostate treatments, and the Multi-Anatomy System for soft tissue anatomy guidance in various applications. These products are designed to enhance radiation therapy planning, verification, and delivery, providing a non-invasive and radiation-free approach that meets the technical and clinical needs of healthcare providers. Resonant Medical serves a range of professionals within cancer treatment centers, including physicians, physicists, therapists, and administrators. In 2010, the company was acquired by Elekta, further solidifying its commitment to advancing patient care in radiation therapy.

Topigen Pharmaceuticals

Series B in 2005
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease. Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.

Topigen Pharmaceuticals

Venture Round in 2004
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease. Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.

Chronogen

Series B in 2003
Chronogen Inc. a biotechnology company headquartered in Montreal, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.